32 Biosciences, a gastrointestinal (GI)-focused biotechnology company pioneering gut mucosal-immune science to prevent and treat GI diseases, today announced that it will officially launch its $40 ...

32 Biosciences revealed its plan to launch a $40 million Series A at this year’s J.P Morgan Healthcare conference, to advance ...

Immune cells expressing the receptor CCR5 are recruited to areas of inflammation by chemokine ligands, making CCR5 an attractive therapeutic target for preventing cell trafficking during conditions ...

A team of researchers has unveiled a revolutionary ingestible bioimpedance sensing device capable of continuously and non-invasively monitoring the integrity of gastrointestinal (GI) mucosal barriers.

To first characterize the Treg populations in the vagina mucosal tissues, the researchers collected samples from healthy women and assayed for Treg abundance and profiled these cells based on which ...

Western diets that are high in sugars, fats, and processed foods have been linked to a wide variety of health ailments. Now, researchers have determined that Western diets can also disrupt the crucial ...

Filoviruses, including Ebola, have the potential to be transmitted via virus-laden droplets deposited onto mucus membranes. Protecting against such emerging pathogens will require understanding how ...

-- The study presents the journey of designing and optimizing novel gut-restricted PHD inhibitors using the comprehensive generative chemistry engine Chemistry42. -- From initiation to preclinical ...